Glucagon-like peptide-1 receptor agonists for treatment of diabetes and obesity: advantage of oral delivery.

Bibliographic Details
Title: Glucagon-like peptide-1 receptor agonists for treatment of diabetes and obesity: advantage of oral delivery.
Authors: New, R. R. C., Bogus, M., Travers, G. N., Hahn, U., Vaiceliunaite, A., Burnet, M., Wang, J. H., Wen, H.
Source: Frontiers in Drug Delivery; 2024, p1-11, 11p
Database: Complementary Index
More Details
DOI:10.3389/fddev.2024.1456654
Published in:Frontiers in Drug Delivery
Language:English